Fox Chase Updates in Bladder and Kidney Cancer 2019
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this program is designed for clinicians who want to stay abreast of the latest advances in bladder and kidney cancer and apply them to their clinical practice. Physicians will present the latest research and its ...
read more ↘
read more ↘
2019 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma: Cisplatin as SoC, Pembro Mono as Alternative for Cis-Ineligible, Chemo +/- Atezolizumab vs. Atezolizumab Alone, Enfortumab Vedotin + Pembro, and Subsequent Therapies
Elizabeth R. Plimack, MD, MS, Fox Chase Cancer Center, Philadelphia, PA
Dr. Plimack is a ...
read more ↘
Dr. Plimack is a ...
read more ↘
Login to view comments.
Click here to Login
